Venture Kick backs CHD with €160K to advance remote pregnancy monitoring

Medtech startup CHD (Connected Health
Development) has received approximately €160,000 (CHF 150,000) from Venture Kick to develop its digital solutions for remote maternal and fetal monitoring.
The company’s technology is designed to help healthcare professionals monitor
high-risk pregnancies outside hospital settings.

More than 140 million babies are born worldwide
each year, with approximately 15 per cent of pregnancies classified as
high-risk and requiring regular medical monitoring. Frequent hospital visits
can place a burden on expectant mothers and healthcare providers, while staff
shortages and limited hospital capacity create additional challenges for
healthcare systems.

CHD is developing connected health solutions
that combine medical sensors, digital platforms and data analysis to support
remote patient monitoring and clinical decision-making. Its technology aims to
improve access to maternal healthcare, enable earlier detection of potential
complications and reduce the need for hospital visits.

The company’s MONI2 solution uses a washable
smart textile belt to collect maternal and fetal electrocardiogram (ECG) data,
uterine contractions, fetal movements and fetal position. Pregnant women can
access basic health indicators through a smartphone application, while
healthcare professionals receive raw data and predictive indicators through a
secure web portal to support diagnosis and monitoring.

CHD plans to introduce consumer and medical
versions of MONI2 using the same hardware, targeting sales of more than 30,000
kits and subscriptions within four years.

Commenting on the investment, Laurent Vandebrouck, CEO of CHD, said Venture Kick’s support forms part of the
company’s initial seed fundraising effort. He added that other private
investors and a foundation have already committed or are considering funding,
with CHD aiming to complete the round by October.

The funding will support the development,
testing and validation of MONI2’s technology as CHD works towards the
commercial launch of its remote maternal and fetal monitoring solutions.